Science Technology & Innovation


– For Professional Investors Only – 

23 January 2019
The In & Out, Naval & Military Club (Cowdray Room)
4 St. James’s Square, London SW1Y 4JU, United Kingdom

Dress Code: Jacket & Tie, Business Attire. For more information, click here

Join us to hear fascinating presentations from some of the most ground-breaking companies in the medical technology, life sciences, flexible-electronics, alternative energy and artificial intelligence sectors featuring key speakers and representatives from the British Innovation Fund, Attomarker, Pragmatic, Roslin Technologies, and Core Power, Cerracap Ventures, Viome, and Nirveda.

Please email us to register:
View latest event schedule: click here

Confirmed Companies and Speakers:

The British Innovation Fund
Speaker: Simon Hopkins, CEO, Milltrust International Group
The British Innovation Fund, advised by Milltrust Agricultural Investments, seeks world-class science and technology in Britain’s top universities, in particular in the realms of medical technology, life sciences, flexible electronics, agri-science and other innovative advancements. BIF nurtures impactful, early-stage companies – helping them reach their full potential and guiding them to worldwide recognition and success. The Fund carefully picks spin-out companies from the established, in-house university commercialisation vehicles which the Fund has invested with.

Prof Andrew Shaw, Founder & CEO, Attomarker
Attomarker, a spin-out from the University of Exeter, is a digital health technology company which has developed a small, simple-to-use blood-testing device that can perform blood tests from a single pin-prick of blood, with results in around five minutes. This multi-patented technology collects the blood sample on a disposable credit-card sized chip which slots into a fully mobile device, docked to an iPhone. The iPhone camera visualises the blood tests which are then interpreted by the iPhone.
Private meetings also available on 22 Jan, or during the event (23 Jan):

Scott White, CEO, PragmatIC
PragmatIC, backed by Cambridge Innovation Capital, is a world leader in the manufacturing of ultra low-cost flexible electronics, enabling the potential for trillions of smart objects that can engage with consumers and their environments. PragmatIC’s unique technology platform delivers flexible integrated circuits that are thinner than a human hair and can be easily embedded into everyday objects.
Private meetings also available during the event:

Roslin Technologies
Glen Illing, CEO, Roslin Technologies
Roslin Technologies is the technology commercialisation company of the University of Edinburgh’s Roslin Institute. Based at Easter Bush Campus, the largest concentration of animal science expertise in Europe, Roslin Technologies exists to deliver breakthrough commercial solutions in the Animal Health, Breeding/Genetics and Animal Nutrition space based on the expert agricultural research of the Institute.
Private meetings also available during the event:

Mikal Bøe, Founder & CEO, CORE-POWER
CORE-POWER is spearheading the development of the world’s first 2-fuel Thorium powered marine engines through an exclusive and perpetual license for technology developed by its US partners and the National Labs in the US. The game-changing technology offers safe and sustainable power with zero climate gas emissions and has a $1 billion revenue potential at just 5% market penetration. The market potential is $1 trillion plus. This new Thorium technology is also set to reduce the energy costs of commercial shipping by 5x (compared to fossil fuels) over the lifetime of a vessel (20 years) at a time when environmental regulations will mandate shipping to cut emissions and ‘de-carbonize’ propulsion. Thorium is the Super-fuel of the future for global shipping.
Private meetings also available on 22 Jan (pm), during the event (23 Jan) or on 24 Jan:

Milltrust Cerracap II
Simon Hopkins, CEO, Milltrust International Group , Saurabh Suri CIO, Cerracap Ventures, & Ritesh Agarwal, Partner, Cerracap Ventures
Cerracap II is dedicated to early-stage technology investments including Enterprise (B2B) products and solutions in the areas of Healthcare, AI and Cyber Security. The fund strategy uses a single approach since inception; targeting great teams with high growth characteristics. CerraCap makes great companies better by personally introducing Fortune 500 decision makers – Sales and Scale model. The fund is managed by Milltrust in Cayman feeding into a US partnership. CerraCap Ventures is headquartered in California with operations in Tel Aviv, Singapore, and Bangalore. Formerly an in-house venture team at UST Global, their prior track record returned a stellar 9x return over 5 years. CerraCap Ventures boasts a phenomenal advisory board including Vincente Fox, former President of Mexico, John C. Cushman, Chairman of Cushman & Wakefield, Richard P Crane Jr., former member of U.S. Department of Justice, and our own Simon Hopkins.
Private meetings also available during the event:

Deepak Savadatti, President, Viome
offers a direct-to-consumer test kit that returns an in-depth look into your gut – and provides dietary advice to help its customers achieve wellness.  It boasts a world-class team, (including a CEO with experience bringing multiple startups to multi-billion dollar IPOs), the most advanced proprietary technology in the field, and a deeply compelling business strategy. The microbiome space is erupting. Scientists have recently (2013) uncovered that the microbiome has an unprecedented impact on health and wellness. Since the discovery, HMP investigators have published over 650 scientific papers that have been cited over 70,000 times.  The gut impacts our immune system, mental health, our development of chronic diseases, autoimmune disorders (such as Alzheimers), diabetes, heart problems, and more. Our gut bacteria governs our bodies more than we knew. Through its AI engine, Viome can then generate highly personalized, actionable nutritional recommendations to dramatically improve vitality, wellness and the body’s overall functions.
Private meetings also available during the event:

Nirveda Cognition
Jordan Hochenbaum, CTO, Nirveda
Nirveda Cognition is the developer of an enterprise AI platform that brings the benefits of AI to back-office processes.  The Company’s platform is capable of augmenting and replacing skilled and semi-skilled labor for repetitive back-office tasks, where improvements can have massive impacts on cost and productivity. According to IDC, 90% of unstructured data is never analyzed. Traditional AI solutions have difficulty processing unstructured information, which represents the vast majority of enterprise data. This leaves employees with the challenging task of manually identifying, locating and interpreting this information that is required for various back-office processes. The Company’s solution harnesses the power of cognitive search, intelligent process automation, and natural language generation into a unique, ground-breaking offering.  By combining these capabilities into a single platform, the Company’s solution enables organizations to automate end-to-end content-centric business processes that until now relied on human cognition, while simultaneously eliminating human error. The Nirveda platform uncovers, interprets and transforms unstructured and semi-structured data (“dark data”), automating business processes faster and more efficiently, while its Continuous Learning features ensure process improvements over time.
Private meetings also available during the event:

Newcastle University AgriTech Research
Speaker: Prof Neil Boonham, Chair of Applied Crop Science, Newcastle University
Over the last 5 years Newcastle University has been involved in major regional and national Agri-Tech initiatives. The University is a member of two of the national AgriTech Centres – CHaP and CIEL. Investments have been made in new state-of-the-art research facilities in digital and diagnostic technologies in crop and livestock research respectively at NU’s Research Farms. Our specific expertise in 1) Crop and Soil Science includes: plant-insect & plant microbe interactions, engineering photosynthesis, crop performance, field phenotyping, disease detection, soil health, herbicide selectivity, resistance to agrochemicals and 2) Animal Sciences includes: animal behaviour/health/welfare, animal nutrition and resource efficiency, systems modelling, precision livestock farming.
Private meetings also available during the event:

Keynote Guest Speaker: Kirk Sorensen, CEO of Flibe Energy, former NASA scientist and advocate of Thorium as the total solution for the world’s energy requirements.
Kirk Sorensen is the founder of Flibe Energy and currently serves as President and Chief Technologist. Kirk has been a public advocate for thorium energy and liquid-fluoride thorium reactor (LFTR) technology since creating the weblog “Energy From Thorium” in 2006. Kirk has a master of science degree (2014) in nuclear engineering from the University of Tennessee and a master of science degree (1999) in aerospace engineering from the Georgia Institute of Technology, and a bachelor’s of science degree (1998) in mechanical engineering from Utah State University. He first learned about thorium and molten-salt reactor technology in March 2000 shortly after joining NASA’s Marshall Space Flight Center in Huntsville, Alabama, following his graduation from the Georgia Institute of Technology. After eight years at NASA MSFC, he was detailed to the US Army’s Space and Missile Defense Command (SMDC) beginning in June 2008. In 2010 he joined Teledyne Brown Engineering as their Chief Nuclear Technologist. With encouragement from Teledyne management, he left in spring 2011 to form Flibe Energy. Kirk has been a prominent advocate for thorium energy with regular speaking engagements and media interviews across the world.
Private meetings also available during the event:

DISCLAIMER: For professional investors only. This document is strictly private and confidential and is meant as guidance and information only. It is issued by Milltrust International LLP, incorporated in the United Kingdom, which is authorised and regulated by the Financial Conduct Authority. Milltrust International LLP has its registered office at 5 Market Yard Mews, 194-204 Bermondsey Street, London, SE1 3TQ, United Kingdom and is a subsidiary of Milltrust International Group (Singapore) Pte Ltd. East India Capital Management Pte Ltd. is a subsidiary of Milltrust International LLP and is registered with the Monetary Authority of Singapore as a Registered Fund Management Company (RFMC). This document is strictly private and confidential and is meant as guidance and information only. It is issued by Milltrust International LLP,   The content in this document is for informational purposes only and does not constitute legal, tax, investment, financial, or other advice. Nothing contained in this document constitutes a solicitation, recommendation, endorsement, or offer by Milltrust International LLP or any of its affiliates to buy or sell any securities or other financial instruments. No such solicitation or offer is made in this or in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction. All content in this document is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in the document constitutes professional and/or financial advice, nor does any information on the document constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. It should therefore not be used as the sole basis for any investment or other decision. The use of or access to this document or content by any person does not create a fiduciary relationship between such person and Milltrust International LLP. The sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this document before making any decisions based on such information or other content rests with the user and their professional advisers.
Copyright © 2019 Milltrust International LLP. All rights reserved.
Milltrust International LLP
6 Stratton Street
London W1J 8LD
T: +44 (0)20 8123 8316